45.19
0.04%
-0.02
After Hours:
45.22
0.03
+0.07%
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now? - Yahoo Finance
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors - Simply Wall St
Financial Review: UroGen Pharma (NASDAQ:URGN) and Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference - AccessWire
Amphastar Continues To Push Proprietary Portfolio With Focus On Baqsimi - Citeline
Algert Global LLC Purchases New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar initiated with an Equal Weight at Wells Fargo - MSN
Connor Clark & Lunn Investment Management Ltd. Sells 20,448 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Segall Bryant & Hamill LLC Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated at Wells Fargo & Company - Defense World
Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle By Investing.com - Investing.com South Africa
GSA Capital Partners LLP Invests $303,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Wells Fargo Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight Recommendation - MSN
Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle - Investing.com
Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016. - Marketscreener.com
Victory Capital Management Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Victory Capital Management Inc. Has $10.61 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Injectables Contraceptives Market with Promising Opportunity - openPR
Principal Financial Group Inc. Has $9.80 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat
Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com India
Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire
Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan
Amphastar Pharmaceuticals Inc (AMPH) Stock Price Down 3.5% on No - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by US Bancorp DE - Defense World
FDA Approves Amphastar's New Epinephrine Drug, Boosting Market Growth - openPR
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings - MSN
Amphastar Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by New York State Teachers Retirement System - Defense World
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of Stock - MarketBeat
William J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Amphastar Pharmaceuticals executive sells $271,388 in stock By Investing.com - Investing.com Nigeria
Amphastar Pharmaceuticals executive sells $271,388 in stock - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 3.62% on Nov 8 - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownTime to Sell? - MarketBeat
Amphastar: Q3 Earnings Snapshot - Houston Chronicle
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - AccessWire
Amphastar Q3 Revenue Hits $191.2M; BAQSIMI Sales Shine as Board Boosts Buyback Program | AMPH Stock News - StockTitan
Hyaluronidase Market Set for Rapid Expansion (2024-2031): - openPR
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Pre - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Lowered to “Hold” at StockNews.com - Defense World
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):